(1)
|
To appoint Kesselman & Kesselman, a member firm of PricewaterhouseCoopers International Limited, an independent registered public accounting firm, as the Company’s auditors for the year ending December 31, 2016, and authorize the Board to determine the compensation of the auditors;
|
(2)
|
To approve the following resolutions with regard to the compensation of Dr. Dov Tamarkin, the Company's Chief Executive Officer:
|
|
(a)
|
grant Dr. Tamarkin a cash bonus of $181,837 for the year ended December 31, 2015, based on the achievement of the goals set and evaluated by the Compensation Committee;
|
|
(b)
|
increase Dr. Tamarkin’s annual base salary to $385,000, effective November 1, 2015; and
|
|
(c)
|
award Dr. Tamarkin 100,000 options under the Company’s 2015 Israeli Share Incentive Plan.
|
(3)
|
To approve Dr. Tamarkin’s (a) annual cash bonus for the year ending December 31, 2016, up to a maximum amount of $231,000, subject to achieving the key performance indicators detailed in the Proxy Statement, and (b) an additional special cash bonus, for the year ending December 31, 2016, in an amount of up to $231,000, upon unique success beyond expectations in achieving certain goals that are further described in the Proxy Statement, in each case, subject to the recommendations of the Company’s Compensation Committee and the Board’s approval.
|
(4)
|
To approve Mr. Eini’s (a) annual cash bonus for the year ending December 31, 2016, up to a maximum amount of $184,500, subject to achieving the key performance indicators detailed in the Proxy Statement, and (b) an additional special cash bonus, for the year ending December 31, 2016, in an amount of up to $184,500, upon unique success beyond expectations in achieving certain goals that are further described in the Proxy Statement, in each case, subject to the recommendations of the Company’s Compensation Committee and the Board’s approval.
|
FOAMIX PHARMACEUTICALS LTD.
|
|||
Date: April 20, 2016
|
By:
|
/s/ Meir Eini | |
Name: Meir Eini | |||
Title: Chairman of the Board of Directors | |||